Upgrading respiratory care with digital medicines
Amiko is a global provider of hardware enabled, AI powered digital medicines. Amiko’s first product is Respiro, a digital medicine product that upgrades respiratory care using proprietary sensing technology, cognitive computing and elegant digital experiences
combines connected inhaler sensors, digital experiences and data science to help deliver better outcomes
Sensors
Patients use Respiro by attaching a sensor to their existing inhalers or by using inhalers with built in sensors. The sensors automatically track user generated flows through the inhaler, and connect wirelessly to the patient’s smartphone
Patient App
The mobile app serves as a companion to the sensors, reminding patients when it’s time to inhale a dose and providing personalized insights and feedback powered by data and artificial intelligence to help patients achieve better outcomes
Provider Portal
The provider portal displays a dashboard of patient data, notifications about patients who are at risk for exacerbations, and monthly reports on each patient’s progress, enabling efficient and effective monitoring of large patient populations
Respiro is proven to improve adherence, inhaler technique and health outcomes
Higher levels of medication adherence
Improved inhaler technique
Better asthma control
1. Chan et al., 2015
2. Sanchis et al., 2016
3. ACT4Y randomized controlled trial, 2019
Patient interested
in Respiro?
Right now Respiro is only available through healthcare partner programs. Join our mailing list if you want to be contacted when our products are available for sale
Provider interested
in Respiro?
Right now Respiro is only available through healthcare partner programs. If you are interested in a partnership, contact us using the form below
Interested in upgrading
your inhaler product?
Contact us using the form below if you would like to discuss a custom digital medicine for your inhaler product
